Clinical Trial Update: Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a novel form of anaplerosis to treat mitochondrial dysfunction in Ataxia-telangiectasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ataxia-telangiectasia

Snippet

Sponsor: The University of Queensland | Conditions: Ataxia Telangiectasia | Phase 2 | Status: COMPLETED